AI and Wearables for Early Detection of Cognitive Impairment and Dementia: Systematic Review
KI und Wearables zur Früherkennung von kognitiver Beeinträchtigung und Demenz: systematische Übersichtsarbeit
Journal of Medical Internet Research · 2026-02-23 · 28 · e86262
DOI: 10.2196/86262 ↗Auf einen Blick
49 Studien zeigen: Wearable-Daten zu Schlaf, Aktivität und circadianen Rhythmen wurden mit kognitiven Outcomes verknüpft. KI-Modelle erreichten AUC-Werte von etwa 0,70 bis 0,95.
Fragestellung
Welche Evidenz gibt es zu Wearables für die frühe Erkennung und Prävention von kognitiver Beeinträchtigung und Demenz?
Methode
Systematische Übersichtsarbeit; Suche in PubMed, Scopus, ACM Digital Library und SpringerLink für Studien von Januar 2020 bis 1. Dezember 2025; narrative Synthese nach PRISMA 2020.
Ergebnisse
49 Studien; Stichprobengrößen von 14 bis 91.948, >200.000 insgesamt. Meist Actigraphy (43/49); kognitive Outcomes häufig MMSE (18/49), ICD-10-Diagnosen (7/49) und MoCA (7/49).
Einschränkungen
Heterogenität der Geräte, Outcomes und Analysen verhinderte Metaanalyse; kleine Stichproben, kurze Monitoringdauer und begrenzte externe Validierung.
Schlussfolgerung der Autor:innen
Wearable-basierte Verhaltensmarker zeigen Potenzial für frühe Risikostratifizierung. Continuous passive monitoring könnte subtile Verhaltensänderungen erfassen und frühere, personalisierte Risikoreduktion unterstützen.
Kernaussagen
- Wearable-Daten wurden häufig mit kognitiven Outcomes verknüpft.
- KI-/Deep-Learning-Modelle zeigten AUC-Werte von etwa 0,70 bis 0,95.
- Etwa ein Viertel der Studien adressierte frühe Erkennung oder Prävention.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
At a glance
Systematische Übersicht in Journal of Medical Internet Research, published online on 2026-02-23. Written by Ander Cejudo and 3 co-authors. Institution: Vicomtech Foundation, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Spain. Major MEDLINE topics: Dementia, Wearable Electronic Devices, Cognitive Dysfunction, Artificial Intelligence. Cited 17 times so far (Crossref); 88 references. The full text is freely available in PubMed Central.
Topics: Demenz
Abstract (original language)
Background
Traditional cognitive screening relies on episodic clinical assessments and may miss early changes preceding cognitive impairment and dementia. Wearable and mobile health technologies enable continuous monitoring of sleep, physical activity, and circadian rhythms, generating digital biomarkers that may support scalable early detection and prevention. However, current evidence remains fragmented across devices, analytic approaches, and cognitive outcomes.
Objective
This study synthesizes and critically evaluates recent evidence on wearable devices for early detection and prevention of cognitive impairment and dementia, focusing on device categories, cognitive outcomes, analytic approaches, and prevention relevance.
Methods
We searched PubMed, Scopus, ACM Digital Library, and SpringerLink for peer-reviewed studies published between January 2020 and December 1, 2025. Eligible studies included human participants with a mean age ≥50 years, continuous wearable-derived data collected for ≥24 hours, and validated cognitive outcomes; reviews, protocols, smartphone-only studies, and pharmacological interventions were excluded. Two reviewers independently screened studies, extracted data, and assessed risk of bias using the Appraisal Tool for Cross-Sectional Studies, Newcastle-Ottawa Scale, Cochrane Risk of Bias tool, and Quality Assessment of Diagnostic Accuracy Studies-2. Owing to substantial heterogeneity in devices, outcomes, and analytic methods, quantitative meta-analysis was not feasible; a structured narrative synthesis was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidance. This study was not prospectively registered.
Results
We included 49 studies, with sample sizes ranging from 14 to 91,948 participants (>200,000 total) and a median sample size of 145. Most used research-grade actigraphy (43/49, 87.8%), while fewer used commercial wearables (7/49, 14.3%). Cognitive outcomes most frequently relied on global screening instruments, including the Mini-Mental State Examination (18/49, 36.7%), followed by ICD-10 (International Statistical Classification of Diseases, Tenth Revision)–based clinical diagnoses (7/49, 14.3%) and the Montreal Cognitive Assessment (7/49, 14.3%). Analytic approaches were predominantly statistical (36/49, 73.5%), with fewer studies applying machine learning (7/49, 14.3%) or deep learning methods (6/49, 12.2%). Statistical analyses linked disrupted sleep, circadian rhythm fragmentation, and irregular activity patterns to worse cognitive outcomes, with modest-to-moderate effect sizes. Machine learning and deep learning approaches reported classification performance with area under the curve values between approximately 0.70 and 0.95. Approximately one-quarter of the studies (13/49, 26.5%) addressed early detection or prevention through longitudinal risk estimation or predictive modeling. Key limitations included small sample sizes, short monitoring durations, and limited external validation.
Conclusions
Wearable-derived behavioral markers show promise for early risk stratification. This review advances the field by shifting from descriptive associations toward a digital phenotyping framework evaluating artificial intelligence–driven prediction in the preclinical window. Unlike prior reviews focused on established dementia, it differentiates direct predictive evidence from indirect correlational findings and critically assesses methodological maturity. Continuous, passive monitoring may enable scalable detection of subtle behavioral changes, supporting earlier and more personalized risk reduction strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Vicomtech Foundation, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Spain.
- Faculty of Engineering, University of Deusto, Bilbao, Spain.
- Biodonostia Health Research Institute, e-Health Group, San Sebastián, Spain.
ORCID profiles: Ander Cejudo, Markel Arrojo, Cristina Martín, Aitor Almeida
Cite
APA
Cejudo, A., Arrojo, M., Martín, C., & Almeida, A. (2026). AI and Wearables for Early Detection of Cognitive Impairment and Dementia: Systematic Review. Journal of Medical Internet Research, 28, e86262. https://doi.org/10.2196/86262
Vancouver
Cejudo A, Arrojo M, Martín C, Almeida A. AI and Wearables for Early Detection of Cognitive Impairment and Dementia: Systematic Review. Journal of Medical Internet Research. 2026;28:e86262. doi:10.2196/86262
BibTeX
@article{Cejudo2026,
author = {Cejudo, Ander and Arrojo, Markel and Martín, Cristina and Almeida, Aitor},
title = {AI and Wearables for Early Detection of Cognitive Impairment and Dementia: Systematic Review},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e86262},
doi = {10.2196/86262}
}
EUVIMED